Drugs / Baby-Hib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05401305 | Jan → Mar 2020 | haemophilus infectious disease | St. Petersburg Research Institute of Vaccines and Sera | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Baby-Hib | “of "Baby-Hib [Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b], Lyophilizate for Preparation of Intramuscular Injection Solution, 0.5 mL/Dose"” NCT05401305 ↗ |
| Modality | Vaccine | “Vaccine for the prevention of infections caused by Haemophilus influenza type b” NCT05401305 ↗ |
| Route | Intramuscular | “once intramuscularly” NCT05401305 ↗ |